Suchergebnisse - "Uchino, Junji"

PubPharm (175)

81

Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients

enthalten in: Translational lung cancer research | 2019

von Yoshimura, A. | Yamada, T. | Okuma, Y. | +16

82

Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study)

enthalten in: Translational lung cancer research | 2019

von Iwasaku, M. | Uchino, J. | Yamada, T. | +6

83

Osimertinib in first line setting : for Asian patients

enthalten in: Translational lung cancer research | 2019

von Onoi, K. | Kaneko, Y. | Uchino, J.

CommentOn: J Thorac Oncol. 2019 Jan;14(1):99-106. - PMID 30240852

84

Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer

enthalten in: Translational lung cancer research | 2019

von Yoshimura, A. | Uchino, J. | Hasegawa, K. | +7

85

Rationale and Design of a Phase II Trial of Osimertinib Combined With Bevacizumab in Patients With Untreated Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer and Malignant Pleural and/or Pericardial Effusion (SPIRAL II Study)

enthalten in: Clinical lung cancer | 2019

von Hiranuma, O. | Uchino, J. | Yamada, T. | +5

86

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment : A Phase II Trial

enthalten in: The oncologist | 2019

von Nakao, A. | Hiranuma, O. | Uchino, J. | +26

87

Coefficients in the CAVI Equation and the Comparison Between CAVI With and Without the Coefficients Using Clinical Data

enthalten in: Journal of atherosclerosis and thrombosis | 2019

von Takahashi, K. | Yamamoto, T. | Tsuda, S. | +9

CommentIn: Vasc Health Risk Manag. 2019 Sep 13;15:395-398. - PMID 31686831

88

Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer

enthalten in: Investigational new drugs | 2019

von Chihara, Y. | Date, K. | Takemura, Y. | +10

89

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer

enthalten in: Cancer medicine | 2019

von Yamada, T. | Hirai, S. | Katayama, Y. | +14

90

Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical medicine | 2019

von Nishioka, N. | Uchino, J. | Hirai, S. | +11